Demal200 x 30mls

Do you fully understand the danger of malaria?

According to the World Health Organization (WHO) every year about 350 million around the world will suffer from malaria. From this number approximately 2 to 3 million will die. Malaria is still the biggest health problem for developing tropical and sub-tropical countries. Whether a victim suffers from serious attacks or the lingering and debilitating effects of prolonged chronic malaria this disease can become a recurring health problem that goes on for years and ultimately shortens life.

The debilitating effects of malaria significantly affect an individual's quality of life both physically and mentally. Apart from taking lives, the malaria parasite can cause serious damage to the liver, kidneys, gal-bladder, spleen and brain function. It is not uncommon to see both children and adults suffer significant organ dysfunction after surviving serious attacks of malaria.

The malaria parasite has so far succeeded in developing resistance to every available drug. Multi-drug resistant strains of malaria are now a major problem in many tropical countries. Demal200 offers a completely new approach to malaria treatment by acting on the human immune system and not by directly attacking the parasite with chemicals. Because of this approach Demal200 can never create a new strain of resistant malaria.

What is the difference between DEMAL200 and other malaria medicines?

Demal200 is an alternative treatment that comes from the homoeopathic system of medicine. This system was perfected in Germany in 1796. In this system of medicine the human immune system is stimulated and strengthened to respond to specific diseases and medical problems. The way a homoeopathic medicine functions is very similar to a vaccine, however the effect on the immune system is much deeper. Achieving this effect on the human immune system requires very careful selection of specific plants and other natural components. Once selected, these components are processed using the unique homoeopathic process which extracts and amplifies the deep healing powers stored within the molecules of each herbal component.

Chemical drugs used for malaria treatment do not assist the natural healing processes of the human body; instead they act chemically on the parasite as a controlled poison. Chemically based drugs are designed to poison the malaria parasite in the hope that the parasite will be killed before the drugs begin to cause harmful side effects to the body's organs. These side effects are clearly stated on the packets of all currently available malaria drugs.

Mode of action:

How does DEMAL200 defeat the malaria parasite?

Pharmacology: Demal200 works as a powerful allergen at the molecular level to cause a rapid mobilization of the immune system. The human immune system is frequently defeated by two characteristics of the malaria parasite.

Firstly, the parasite possesses a protein coating, which is recognized by the antibodies as the parasite's identifying feature. When the parasite comes under attack from antibodies it changes its protein coating and confuses the immune system long enough to reproduce and compensate for losses to the antibodies. When the immune system finally recognizes the new protein coating and renews the attack, the parasite changes it again. The parasite can use this masking defence indefinitely. Demal200 uses homoeopathically potentized phosphorous which paralyses the parasite and stops it from changing its protein coating. Simultaneously, the other components of the medicine cause rapid and wholesale production of antibodies which overwhelm the parasites before they can reproduce.

The second characteristic is the ability of the parasites to invade red blood cells and attach themselves to special dendritic cells that normally activate the immune system by stimulating T-cells in the blood. The parasites disable the dendritic cells and prevent them from activating T-cells that in turn stimulate the immune system to launch an appropriate response to the malaria parasite by producing large numbers of antibodies. Because the malaria parasite can neutralize the immune system's ability to signal the need to produce extra antibodies it can reproduce and destroy red blood cells much faster than the body can respond. The immune stimulants in Demal200 are able to activate the T-cells so that they can signal the need for extra antibodies.

Dosage & Administration

How is this medicine used to treat a normal malaria attack?
Administration of Demal200 for acute cases (normal malaria attack) is very simple and acts quickly against malaria parasites.

REPORT: MALARIA TREATMENT PROMOTION

AND COMMERCIAL LAUNCHING OF

DEMAL200 (ANTI-MALARIA MEDICINE)

FLORES, EAST NUSA TENGGARA PROVINCE,

INDONESIA

Background

On June 14, 2000 it was decided to launch DEMAL200 by conducting a free malaria treatment promotion in Flores. The promotional activity was to have two main objectives. Firstly, to raise awareness of the worsening malaria problem in eastern Indonesia; and secondly, to introduce DEMAL200 to an endemic malaria area where its unique treatment qualities could be experienced first hand by health workers who routinely deal with large numbers of malaria cases.

On the 31^st of October, and the 1^st, 2^nd and 3^rd of November Blue Turtle Remedial Sciences conducted a free malaria treatment promotional activity located at Santa Maria of Guadalupe Clinic located at Wudu village and St. Josep Clinic located at Ndora village. Both these clinics are located in the Ngada District (Kabupaten) of Central Flores.

Observations After Treating 124 Malaria Patients With DEMAL200

The nursing sisters who supervised the free malaria treatment promotion for 124 patients at the Ndora and Wudu clinics followed closely the administration and dosage instructions provided for each case type. The presence of malaria parasites, and the type of malaria, was confirmed by blood tests before and after DEMAL200 was used to treat each patient. Unfortunately, due to patient over load and a shortage of skilled laboratory staff at Wudu clinic only 9 patients had data recorded regarding the type of parasites detected in their blood tests. Due to time constraints the remainder were simply identified as positive malaria infections.

In order to prove DEMAL200’s unique ability to expel parasites from chronically infected patients it was decided to divide the promotion participants into two main treatment groups:

1. Acute patients were defined as patients suffering from active malaria at the time of treatment and confirmed as having parasites in their blood prior to administering DEMAL200. Virtually all the acute patients were also classified as chronic cases (Acute/Chronic) due to the high incidence of multiple malaria infections. All of the patients treated at St. Josep’s clinic at Ndora were acute cases, while 9 of the 74 cases treated at Wudu clinic were also acute cases. All 59 acute cases were successfully treated.

2. Chronic patients were defined as patients who had a well documented medical history of recurrent malaria but who were not suffering any malaria symptoms at the time of treatment. The treatment objective with chronic cases was to administer DEMAL200 in 5 minute doses to initiate an immune reaction thereby proving that residual parasites were still in their livers. The presence of parasites was then confirmed by a blood test as soon as the reaction began. Once the reaction was confirmed DEMAL200 was then given continuously in 30 minute doses until a complete cure (as defined by parasite negative blood tests) was achieved. Due to the completeness of medical records on malaria cases collected at the Santa Maria of Guadalupe Clinic at Wudu, it was decided to use this clinic to concentrate on the treatment of chronic cases. A total of 65 chronic cases were successfully treated at the Wudu clinic; that is to say, all 65 patients experienced the standard set of reactions after the initial intensive dosage and all were later tested negative for parasites.

The following general observations were made by the sisters after four days of treating patients with DEMAL200:

 A. The dosage used for adults and children was the same, and proved to be fast working and very effective. This fact was graphically proven after two seriously ill 16 month old babies were treated at both Wudu and Ndora clinics for highly acute falciparum malaria. Both babies were allowed to go home after two and half hours of intensive treatment. No side effects were observed at all during the treatment and the children are still malaria free according to reports from Flores.

 B. DEMAL200 effectively treated all strains of malaria, both mono-strain and multi-strain (mainly vivax and falciparum combinations) cases within 12 to 36 hours. Post-treatment blood tests confirmed that parasites were no longer present.

 C. The pleasant taste of DEMAL200 and the ease of administration was well received by all patients, especially children. The sisters noted that simply spraying the medicine under the tongue was a major advantage when treating small children.

 D. The wide range of reactions experienced after using DEMAL200 were the source of much interest (and amusement) among the sisters and patients. All participants were fully briefed before the treatment about what reactions they could expect after taking the medicine. When the reactions occurred as predicted the patients described them in detail to the sisters and then began comparing reactions with other patients. The types of reactions noted (and experienced by the sisters who were also treated) after administering the medicine included the following:

1. Mild headaches and dizziness.

2. Tension in the back of the head, neck and trapezius muscles.

3. Light headedness and slightly blurred vision.

4. Nausea (in some cases the patients vomited and afterwards felt better).

5. Hot flushes (often accompanied by redness in the face).

6. Redness in the eyes.

7. Sweating (hot and cold).

8. Mild to severe drowsiness (in some cases the patients could not stay awake).

9. Discomfort and feelings of movement in the liver and spleen.

10. Dyspepsia.

11. Acute and mild delirium. This reaction only occurred with patients who routinely suffered delirium during previous malaria attacks. The types of delirium ranged from talking and laughing to themselves, and in one case a 17 year old youth climbed a tree and pretended it was a truck.

12. Muscle and joint aches, and back pain.

13. Directly after the first set of reactions finished many patients felt very hungry.

14. Short-term allergic-type itching (although no rashes were observed).

15. Diarrhea.

Specific Cases

Aris Hubertus (4 yrs)

The first case treated at the Ndora clinic was a 4 year old orphan boy named Aris Hubertus. According to the sisters who look after him, Aris had been a long-term sufferer of malaria. He had been affected to such an extent by continuous attacks of falciparum malaria that he now experienced delirium with every attack. The delirium was always accompanied by high fevers and took the form of running around aimlessly, laughing and talking to himself.

 Within 10 minutes of being sprayed with DEMAL200 Aris’s face began to flush red and he started sweating. After approximately 40 minutes of continuous dosing Aris began to smile and mutter to himself. The sisters commented that this was the way the delirium usually began.

During day one and two Aris tested positive for falciparum parasites and felt sleepy, hungry and complained of discomfort in his liver. By day three his blood tested negative for parasites, although he still felt some mild drowsiness.

Lidya Tho (28 yrs)

The first highly acute case came into the clinic at Wudu at 08:00 in the morning on the first day of the free treatment promotion. Lidya had to be accompanied by two other women who practically carried her into the clinic shivering and barely aware of her surroundings. She had come from a cold mountain region of Flores and had never had malaria before. She had recently married and had followed her husband to Wudu where she contracted falciparum malaria.

On arrival at the clinic she had a high fever and tested positive for falciparum malaria parasites. Sister Lus Maria (pictured together) immediately began intensive dosing with DEMAL200 as instructed. In less than an hour Lidya’s body temperature had returned to normal, but she remained very tired and weakened by the experience. At 10:30 sister Maria allowed her to go home after giving her a vitamin injection. She returned the next two days for follow up blood tests and tested negative for parasites both times.

Ben Lako (72 yrs)

Among the first days patients was Ben Lako who had been a chronic sufferer after multiple infections of falciparum over many years. He also suffered from mild delirium when he had an attack of malaria. Although his blood was positive with parasites when he begun treatment he was not feeling any significant malaria symptoms. Within 10 minutes after being sprayed he began to feel dizzy and hot. Light sweats were also noticeable. After about 30 minutes he started muttering to himself.

He followed the dosage instructions and returned the next day and reported feeling drowsy. His blood still tested positive on the second day. He returned the third day and tested negative for parasites, commenting that he felt much better than he had felt for a long time.

Fabianus Dua (54 yrs)

A few hours prior to the arrival of the team at the Ndora clinic Fabianus was brought into the clinic by neighbours who had just coaxed him down after spending most of the night up a coconut tree. He climbed up the tree while in a delirious state with falciparum malaria. Although he frequently suffered from malaria induced delirium attacks according to his neighbours, he had never before managed to climb a coconut tree. As expected, his blood tested positive for malaria falciparum.

After three sprays of DEMAL200 (10 minutes) he politely excused himself saying he could not keep his eyes open any longer and went straight to sleep. He did not wake up again for about four hours at which time he continued to be given the recommended dosage by the sisters. He still complained of drowsiness and a mild headache on the second day, but commented that this was the most pleasant medical treatment he had ever undergone. His blood tested negative for parasites on the second day.

Yosefina Soli (37 yrs)

The day before our arrival, Yosefina had been admitted to the in-patients ward with an acute attack of malaria induced delirium. She was a regular visitor at the clinic because of her malaria problem and on this occasion tested positive for falciparum malaria. Her delirium made her very restless. She talked to herself, walked around the clinic trying to mop the floors and constantly tried to rearrange the furniture.

 About 15 minutes after being sprayed with DEMAL200 her face flushed red and she felt dizzy and commented that she felt sleepy. She then went to bed and slept for about 40 minutes after which she awoke and started to display signs of delirium again. She continued to be dosed every 30 minutes and experienced more periods of mild delirium interspersed by short naps. She tested positive for falciparum malaria on the second day, but negative on the morning of the third day.

Bastiana Dede (34 yrs)

Bastina was a frequent visitor at the Ndora clinic because of her vivax malaria. On the first day of treatment she had tested positive for vivax malaria and had an interesting range of reactions within about 15 minutes of taking DEMAL200. Initially she felt a mild headache and cold sweats. Within about 40 to 50 minutes this progressed to nausea and discomfort in the upper abdomen. At this point she vomited. Her reaction also progressed to a low

level back ache which persisted with the other reactions until early the next day. By day two she still felt weak but tested negative for malaria parasites.

Sisters Kristina (55 yrs) and Anastasia (60 yrs) ( Ndora clinic)

Both of these sisters were long-term chronic sufferers of malaria. Both sisters tested positive for malaria on the first day of the treatment (Sister Kristina – vivax, Sister Anastasia – falciparum) although apart from a low level headache and tiredness, neither was suffering from any pronounced malaria symptoms at the time of treatment. Both were dosed on the morning of the first day of the treatment at Ndora and both experienced significant reactions within about 10 minutes.

Sister Kristina began to feel acute drowsiness and could hardly stay awake. Her face also flushed red and she experienced a fever and sweats. On the second day of the treatment she complained of nausea the night before, but her blood tested negative for parasites on the second day.

Sister Anastasia experienced a strong headache for the first hour or so, then this disappeared. She also felt significant back pain and became very agitated. On the second day Sister Anastasia said her back pain, headache and other symptoms were completely gone and that her body felt very fresh and light. She also tested negative for malaria parasites on the second day.

Sisters Luz Maria (48 yrs) and Marlina (38 yrs) (Wudu clinic)

Both of these sisters were long-term chronic sufferers of malaria. Both sisters tested positive for malaria parasites the day before the treatment (Sister Luz Maria – vivax, Sister Marlina – falciparum). Neither was suffering from any pronounced malaria symptoms at the time of treatment. Both were dosed on the night before the first day of the treatment at Wudu clinic and both experienced significant reactions within about 10 minutes of their first dosing.

 Sister Luz Maria began to feel tension in the head and back of the neck which then progressed to drowsiness. She also developed a light fever and sweats. On the first day of the treatment she complained of heavy night sweats after receiving her first few doses of DEMAL200. She continued to sweat heavily throughout the first day of the treatment. Her blood tested positive for parasites on the second day, but negative on the third day.

Sister Marlina experienced dizziness and her face flushed red. She later developed a low-level headache which continued into the next day. She continued to feel the low level headache through the first day of the treatment as well as muscle aches in her legs. Her blood also tested positive for parasites on the second day, but negative on the third day.

Petrus Lino (45 yrs)

Petrus Lino experienced an unusual reaction after using DEMAL200 that proved to the supervising sisters one of the unique qualities of DEMAL200. That is, DEMAL200 expels parasites from the liver into both the blood stream and the bowel. Petrus was a frequent visitor at the clinic due to his vivax malaria. He tested positive for vivax malaria when he arrived at the clinic although he was not suffering any significant malaria symptoms at the time he started taking DEMAL200.

Unlike the vast majority of patients who experienced a reaction within 10 to 20 minutes after taking the medicin, Petrus felt nothing. Since his blood test was positive and he was a regular sufferer of vivax malaria it was decided to persist with the initial dosage of one spray every 5 minutes which is usually successful in stimulating a quick reaction within 10 to 20 minutes. After one hour Petrus still felt nothing, however, he was told to continue with the 5 minute dosage. About four and fourty-five minutes after his first dose of DEMAL200 Petrus complained to the sister that was monitoring him that he felt sudden and sharp diarrhea pains in the bowel and needed

to relieve himself. He then had a rather violent bowel motion and the sister monitoring him noted that the feaces he passed was bright yellow in colour.

The next day his blood tested negative for malaria parasites. It was assumed that his delayed reaction to the medicine was caused by the longer time required by his liver to expel the malaria parasites into his bowel, and not into his blood stream as usually happens after using the medicine with intensive 5 minute doses.

Conclusions And Lessons Learned

• During the four days of the free treatment promotion activity in Flores the team from Blue Turtle Remedial Sciences had an excellent opportunity to see malaria at its worst, and DEMAL200 at its best. The observations detailed above were also an accurate portrayal, and confirmation of the reports received from hundreds of other patients who have used DEMAL200 over the last 25 years.

• Comments from the sisters who supervised the free treatment activity, and certain cultural/behavioral aspects of some of the patients, will be used to further fine-tune the instructional leaflets provided with each bottle of medicine. 

• DEMAL200 proved to be far more effective than previously imagined when observed in such an intensive treatment situation. In terms of the objective of the treatment promotion exercise and from a simple clinical viewpoint - DEMAL200 achieved 100% success. All cases treated were confirmed as being positive for malaria parasites with pre-treatment blood tests. The same patients were then retested and found to be negative for parasites after 12 to 36 hours after treatment. A small number of patients had quite delayed reactions compared to the majority of participants who responded on average within 10 to 40 minutes after their first spray of DEMAL200, but what is important to note is ALL 124 PATIENTS RESPONDED. 

• This information was already known prior to the free treatment activity, but the reconfirmation with such a large number of patients, and during such a short time period, was very impressive and will provide valuable evidence for future marketing activities. The ‘Flores Post’ local newspaper has already printed an advertorial promoting DEMAL200, and explaining homoeopathy in general. The advertorial was also accompanied by stories about the free treatment activity. Interviews with the sisters at the two clinics are also soon to be published. The strategy of promotional activity to refocus local awareness about the dangers of malaria through local media appears to have been effective and will be repeated in the local newspapers of Kupang, Jayapura, Riau and other endemic malaria areas. 

• Detailed patient information can be seen in the master patient list attached to this report. This list is a summary of the basic patient data for all 124 patients as recorded by the sisters and their staff during the free treatment promotion.

LIST OF PARTICIPANTS AND TREATMENT DATA

FREE MALARIA TREATMENT PROMOTION WITH DEMAL200

ST. JOSEP CLINIC, NDORA, NGADA DISTRICT, FLORES

LIST OF PARTICIPANTS AND TREATMENT DATA

FREE MALARIA TREATMENT PROMOTION WITH DEMAL200

SANTA MARIA OF GUADALUPE CLINIC, WUDU, NGADA DISTRICT, FLORES

Composition and formula

1. Uncaria Tomentosa Herba           04.32% (original extract) 200C (Potency Factor)
2. Solani Linnaeani Fructus              04.32% (original extract) 200C (Potency Factor)
3. Petroselini Crisps Herba               03.24%  (original extract) 200C (Potency Factor)

In order to reward customers of long standing and others who buy our remedies in volume, BTRS is pleased to announce a series of discount offers as detailed below. Website management isn't our strongest suit so please bear with us if some of these offers are a little clunky in operation: don't hesitate to contact us if you encounter a glitch, we'll fudge our way through it if needs be.

1) Buy 5 Demal200s and receive a 6th Demal free!! (No coupon required: offer is open to all customers)

2) 50% 0ff ImmunoStimulant Spray when purchased with Demal200 (No coupon required: offer is open to all customers)

Demal200's effectiveness is only as good as the immune system's ability to respond to the daily stimulus with it: tropical life is very stressful on the immune system which does become jaded over time. In order to help maintain the immune system in top condition we recommend ImmunoStimulant Spray is used 2x per day for two weeks in every 12. On this basis, BTRS is pleased to offer a discount of 50% off the price of a bottle of ImmunoStimulant Spray when 3 Bottles of Demal200 are purchased.

3) 15% off all order baskets valued over AU$250 (ie 4 bottles)
This offer is available to East African residents only for delivery to non-African addresses to be hand carried to the recipient in East Africa.

4) 20% off all order baskets valued over AU$400 (ie 6 bottles)
This offer is available to East African residents only for delivery to non-African addresses to be hand carried to the recipient in East Africa.